相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence
Alessandro Federico et al.
TRANSLATIONAL RESEARCH (2016)
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor beta by the monoclonal antibody fresolimumab (GC1008)
Mario E. Lacouture et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Signalling pathways involved in the process of mesenchymal stem cells differentiating into hepatocytes
Jun-Song Ye et al.
CELL PROLIFERATION (2015)
PTPRO-Associated Hepatic Stellate Cell Activation Plays a Critical Role in Liver Fibrosis
Xudong Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice
Ahmed Bettaieb et al.
GASTROENTEROLOGY (2015)
Role of Gut Microbiota in Liver Disease
David A. Brenner et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
The Therapeutic Promise of Mesenchymal Stem Cells for Liver Restoration
Bruno Christ et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Early to Phase II drugs currently under investigation for the treatment of liver fibrosis
Peter Hauff et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis
M. V. Machado et al.
GUT (2015)
Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice
J. D. Coombes et al.
GUT (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Role of NADPH Oxidases in Liver Fibrosis
Yong-Han Paik et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
β-Lapachone alleviates alcoholic fatty liver disease in rats
Sanghee Shin et al.
CELLULAR SIGNALLING (2014)
Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo
Chunqiu Hao et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2014)
Caspase 3 Inactivation Protects Against Hepatic Cell Death and Ameliorates Fibrogenesis in a Diet-Induced NASH Model
Samjhana Thapaliya et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme
Ahmed Tayel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
The Portal Fibroblast: Not Just a Poor Man's Stellate Cell
Rebecca G. Wells
GASTROENTEROLOGY (2014)
Mouse Hepatocyte Overexpression of NF-κB-Inducing Kinase (NIK) Triggers Fatal Macrophage-Dependent Liver Injury and Fibrosis
Hong Shen et al.
HEPATOLOGY (2014)
High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)
Xiaodong Ge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
P2X7 blockade attenuates mouse liver fibrosis
Changshan Huang et al.
MOLECULAR MEDICINE REPORTS (2014)
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Ying Wang et al.
NATURE IMMUNOLOGY (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
TGF-β1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway
Ling Fang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Toll-like Receptor 4 (TLR4) Antagonist Eritoran Tetrasodium Attenuates Liver Ischemia and Reperfusion Injury through Inhibition of High-Mobility Group Box Protein B1 (HMGB1) Signaling
Kerry-Ann McDonald et al.
MOLECULAR MEDICINE (2014)
Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats
Do Young Kim et al.
APOPTOSIS (2013)
Deficiency of Intestinal Mucin-2 Ameliorates Experimental Alcoholic Liver Disease in Mice
Phillipp Hartmann et al.
HEPATOLOGY (2013)
Evolving therapies for liver fibrosis
Detlef Schuppan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A Novel Small-Molecule Enantiomeric Analogue of Traditional (-)-Morphinans Has Specific TLR9 Antagonist Properties and Reduces Sterile Inflammation-Induced Organ Damage
Rafaz Hoque et al.
JOURNAL OF IMMUNOLOGY (2013)
Eritoran attenuates tissue damage and inflammation in hemorrhagic shock/trauma
Sebastian Korff et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats
Hong Ling et al.
PLOS ONE (2013)
Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis
Petra Hirsova et al.
PLOS ONE (2013)
Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1
Xiaobao Fan et al.
PLOS ONE (2013)
TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways
Ling Fang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Role of Integrin αvβ6 in the Pathogenesis of Ischemia-Related Biliary Fibrosis After Liver Transplantation
Geng Chen et al.
TRANSPLANTATION (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice
Rafaz Hoque et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
TGF-β Signaling in Onset and Progression of Hepatocellular Carcinoma
Nadja M. Meindl-Beinker et al.
DIGESTIVE DISEASES (2012)
IL-17 neutralization significantly ameliorates hepatic granulomatous inflammation and liver damage in Schistosoma japonicum infected mice
Yuxia Zhang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo
Joy X. Jiang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Sterile Inflammation in the Liver
Paul Kubes et al.
GASTROENTEROLOGY (2012)
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
Fanli Meng et al.
GASTROENTEROLOGY (2012)
Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Experimental Liver Fibrosis: GKT137831 as a Novel Potential Therapeutic Agent
Tomonori Aoyama et al.
HEPATOLOGY (2012)
Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure
Pedro E. Marques et al.
HEPATOLOGY (2012)
Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling
Akshay Pratap et al.
JOURNAL OF DRUG TARGETING (2012)
CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver
Ye Htun Oo et al.
JOURNAL OF HEPATOLOGY (2012)
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis
Laura J. Dixon et al.
LABORATORY INVESTIGATION (2012)
The traditional ayurvedic medicine, Eugenia jambolana (Jamun fruit), decreases liver inflammation, injury and fibrosis during cholestasis
Ajay C. Donepudi et al.
LIVER INTERNATIONAL (2012)
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
Kenneth E. Lipson et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Migration of Fibrocytes in Fibrogenic Liver Injury
David Scholten et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases
Hu Lin et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2011)
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Y. Tang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Gut microbiota and probiotics in chronic liver diseases
Claudia Cesaro et al.
DIGESTIVE AND LIVER DISEASE (2011)
Lineage Tracing Demonstrates No Evidence of Cholangiocyte Epithelial-to-Mesenchymal Transition in Murine Models of Hepatic Fibrosis
Andrew S. Chu et al.
HEPATOLOGY (2011)
IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis
Liyun Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2011)
Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility
Changyong Li et al.
JOURNAL OF HEPATOLOGY (2011)
PET with the 89Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models
Thijs H. Oude Munnink et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Howard Trachtman et al.
KIDNEY INTERNATIONAL (2011)
Cyclopamine Attenuates Acute Warm Ischemia Reperfusion Injury in Cholestatic Rat Liver: Hope for Marginal Livers
Akshay Pratap et al.
MOLECULAR PHARMACEUTICS (2011)
Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer
George M. Philips et al.
PLOS ONE (2011)
Genetic Labeling Does Not Detect Epithelial-to-Mesenchymal Transition of Cholangiocytes in Liver Fibrosis in Mice
David Scholten et al.
GASTROENTEROLOGY (2010)
Signals from dying hepatocytes trigger growth of liver progenitors
Youngmi Jung et al.
GUT (2010)
Role and Cellular Source of Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Hepatic Fibrosis
Samuele De Minicis et al.
HEPATOLOGY (2010)
Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Kojiro Taura et al.
HEPATOLOGY (2010)
Effect of Anthocyanin-Rich Extract from Black Rice (Oryza sativa L. Japonica) on Chronically Alcohol-Induced Liver Damage in Rats
Zhaohua Hou et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis
Quentin M. Anstee et al.
JOURNAL OF HEPATOLOGY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
Inhibition of Endogenous Hedgehog Signaling Protects Against Acute Liver Injury After Ischemia Reperfusion
Akshay Pratap et al.
PHARMACEUTICAL RESEARCH (2010)
Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
Braedon McDonald et al.
SCIENCE (2010)
Hedgehog-Mediated Epithelial-to-Mesenchymal Transition and Fibrogenic Repair in Nonalcoholic Fatty Liver Disease
Wing-Kin Syn et al.
GASTROENTEROLOGY (2009)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis
Rafal P. Witek et al.
HEPATOLOGY (2009)
Repair-Related Activation of Hedgehog Signaling Promotes Cholangiocyte Chemokine Production
Alessia Omenetti et al.
HEPATOLOGY (2009)
Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis
Changyong Li et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatoprotective Effects of an Anthocyanin Fraction from Purple-Fleshed Sweet Potato Against Acetaminophen-Induced Liver Damage in Mice
Jae Ho Choi et al.
JOURNAL OF MEDICINAL FOOD (2009)
Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways
Takashi Nitta et al.
HEPATOLOGY (2008)
Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies
Yury Popov et al.
JOURNAL OF HEPATOLOGY (2008)
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential
L. Valfre Di Bonzo et al.
GUT (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
Role of αvβ6 integrin in acute biliary fibrosis
Bruce Wang et al.
HEPATOLOGY (2007)
Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition
Michael Zeisberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C
Paul J. Pockros et al.
HEPATOLOGY (2007)
NOX in liver fibrosis
Sarnuele De Minicis et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation
Alessia Omenetti et al.
LABORATORY INVESTIGATION (2007)
Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis
Tatiana Kisseleva et al.
JOURNAL OF HEPATOLOGY (2006)
The bone marrow functionally contributes to liver fibrosis
Francesco P. Russo et al.
GASTROENTEROLOGY (2006)
Inhibition of ALK5 as a new approach to treat liver fibrotic diseases
Anne-Charlotte de Gouville et al.
DRUG NEWS & PERSPECTIVES (2006)
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term
M Neef et al.
JOURNAL OF HEPATOLOGY (2006)
Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats
H Yoshiji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis
AC de Gouville et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse
A Canbay et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells
Z Szondy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
